Obstructive Pulmonary Pharmacology (Exam 1b) Flashcards

1
Q

Class of medications that dilate the bronchioles

A

-Beta2-adrenergics

-Inhaled Anticholinergics

-Xanthine derivatives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Class of medications that decrease bronchial inflammation

A

-Glucocorticoids

-Mast cell stabilizer

-LTRA’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Bronchodilators

A

Used to treat all respiratory disease

Work by relaxing bronchial smooth muscle (causing dilation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Beta-Adrenergic Agonists (Bronchodilator)

A

-Can be long or short acting

-Usually end in -erol (both short and long)

-Crucial to know if it short or long acting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Short Acting Beta Adrenergic Agonists

A

-Albuterol (PO/Inhalant)

-Levalbuterol Inhalant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Long Acting Beta-Adrenergic Agonists

A

-Salmeterol

-Formoterol

All long acting are in form of inhalant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Short Active vs Long acting inhalation

A

-Most B2 agonist are short acting (SABA)

-SABA are Rescue drugs

-Duration = 4-6 H

-Long acting B2 agonist are preventer drugs

-Duration = 12-24 H

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Beta-adrenergic Agonist: MOA

A

Mimic action of SNS –> Flight or fight

Relax and dilate the ariways by stimulating the Beta 2 adrenergic receptors throughout the lungs

Causing bronchial dilation and increased airflow into and out of the lungs = goal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Beta-adrenergic agonist: Indications

A

Prevention or relief of bronchospasm related to asthma/bronchitis/other pulmonary conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Beta-adrenergic agonist: NSG considerations

A

Can be given with beta blocker, but may diminish effects (give more)

Avoid use with MAOI and sympathomimetics (ephedrine/sudafed) increase risk of HTN

Diabetics may need higher doses of meds because raises blood sugar

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Beta-adrenergic agonist: contraindications

A

Uncontrolled HTN, cardiac dysrhythmias, high risk of stroke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Beta-adrenergic agonist: Adverse effects

A

hyper or hypo tension

bronchospasm

insomnia
restlessness
anorexia
cardiac stimulation
HA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Inhalers are given

A

minimize systemic side effects

Don’t see cardiac and htn problems as much because we are just aim at the beta 2 receptors in the lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Inhaler PDF on canvas

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Selective Beta Agonist: Albuterol

A

-Short-acting beta2 agonist (SABA): onset is mins

-Inhalation Q4-6H

-Rescue drug

-Delivery method: MDI or nebulizer —> FIRST line of treatment for acute asthma attack

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Albuterol: Rescue Drug

A

Use of more than on canister per month indicates inadequate control of asthma and need for initiating or intensifying anti-inflammatory therapy

(200 actuations per canister)

Also used for prevention of EIA (Exercise induced asthma)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Albuterol: Indications

A

Treatment of COPD umbrella

Acute episodes of wheezing, chest tightness, and SOA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Salmeterol: class

A

LAB2A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Salmeterol: Indications

A

Not for acute treatments –> it is a maintenance drug

Worsening of COPD

Moderate - Severe asthma

Always given with an inhaled corticosteroid, no indicated for monotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Key Point: Salmeterol

A

Always given with an inhaled corticosteroid, not indicated for monotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Salmeterol: Warning

A

Has been associated with increased asthma-related deaths (more common in black AA’s)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Anticholinergics

A

Still type of bronchodilators —> instead of working on beta receptors this works on acetylcholine receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Giving Anti-Cholinergic agents results in

A

-Turning off cholinergic response (PNS) and turning on SNS

-SNS dominates = Bronchodilation (Thus increasing perfusion to heart, lungs, and brain)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Anticholinergic: KEY point

A

-By blocking the effects of acetylcholine (anticholinergic drugs), we INHIBIT the normal physiological response

-Less Bronchoconstriction and less mucus production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
ipratropium: class
Anticholinergics
26
ipratropium: MOA
Blocks action of acetylcholine = creates bronchodilation (by preventing bronchoconstriction)
27
ipratropium: Indications
Used for PROPHYLAXIS and maintenance (not rescue drug) Given in combination with albuterol
28
ipratropium: Adverse Effects
Dry as bone Hot as a hare Blind as a bat Red as a beet Mad as a hatter Urinary retention - DRY everything - Sedation/confusion - Blurred vision - Tachycardia - Feeling hot and decrease sweating
29
Xanthine Derivatives (Bronchodilators)
theophylline aminophylline
30
Xanthine Derivatives: MOA
Increasing levels of the cAMP enzyme by inhibiting phosphodiesterase (Stimulates CNS and CVD system) Used a second line treatment because of the high risk of toxicity and drug-drug interactions
31
Xanthine Derivatives: Indicaitons
Preventative treatment of asthma attacks and COPD exacerbation
32
Xanthine Derivatives: SE
-Toxicity --> N/V/D, insomnia, tachy, seizures (Elderly)
33
Xanthine Derivatives: Contraindications
Uncontrolled cardiac dysrhythmias, seizure disorders, hyperthyroid, peptic ulcers
34
Xanthine Derivatives: Interactions
Caffeine may increase SE (Theophylline) Smoking may decrease absorption
35
Xanthine Derivatives: NSG condsiderations
Has narrow TPI --> monitor serum level and watch for toxicity. If becoming toxic you can use activated charcoal Lots of drug interactions
36
Anti-Inflammatories COPD drugs
LTRA's Inhaled corticosteroids Mast cell stabilizers
37
Leukotriene receptor antagonist (LTRA) drugs
montelukast zafirlukast
38
Leukotriene Receptor antagonist: MOA
LTRA's prevent leukotrienes from attaching to receptors located on immune cells and within the lungs --> prevents inflammation
39
LTRA: Indication
Used for oral prophylaxis and chronic treatment of asthma in adults and children Not used in asthma attacks
40
LTRA: Adverse effects
Headache, nausea, dizziness, insomnia, and diarrhea
41
Which LTRA has more drug-drug interactions
Zafirlukast has more drug-drug interactions vs Montelukast
42
LTRA's and kids
-Montelukast can be given to kids over twelve months but zafirlukast can only be given to kids over 5 yrs
43
Inhaled Corticosteroids
beclomethasone budesonide fluticasone
44
Inhaled corticosteroids: MOA
-Reduces inflammation and enhance activity of beta agonists (also help with bronchodilation)
45
Inhaled corticosteroids: Consideration
PO corticosteroids work immediately and can be used in emergent situations. Inhaled can take several weeks of continuous therapy before full effect of the steroids are realized
46
Are inhaled corticosteroids a rescue drug?
NO They are given for prevention of persistent asthma attacks and long term maintenance of severe COPD For asthma - teach to take on regular schedule, not PRN and give the bronchodilator first to allow more thorough absorption of the steroid
47
Inhaled Corticosteroids: Adverse Effects
Pharyngeal irritation, cough, dry mouth and oral fungal infections RINSE MOUTH AFTER USE
48
49
Combinations of inhaled glucocorticoid and bronchodilator
budesonide and formoterol fluticasone and salmeterol Used for moderate to severe asthma
50
Combination of Inhaled GCS and Bronchodilator: Key teaching
Are never for acute attacks Give bronchodilator first so better absorption for steriods
51
Mast cell stabilizer
cromolyn
52
cromolyn all
Stabilize membranes of mast cells and prevents release of broncho-constrictive inflammatory substances used 15-20 min prior to know trigger. (not rescue)
53
monoclonal antibody anti-asthmatic
omalizumab
54
omalizumab
Newest generation of anti asthmatic indicated for add on therapy (never byself) given via injection
55
omalizumab: MOA
Monoclonal antibody which selectively bind to immunoglobulin IgE --> limits the release of mediators of allergic response
56
omalizumab: big risk
Must be monitored closely for hypersensitivity reactions (anaphylaxis is big risk)
57
Selective PDE-4 inhibitor
roflumilast
58
roflumilast: MOA
Selectively inhibits PDE4 enzyme in the lung cells Potent anit-inflammatory effects within the lungs
59
roflumilast: indications
for prevention of COPD exacerbations (not for acute/immediate action)
60
roflumilast: SE
N/V/D -Decrease appetite -Uncontrollable tremors and muscle spasms
61
Long term Control Medications
1. Anticholinergics 2. Xanthine derivative 3. Inhaled corticosteroids 4. Leukotriene modifiers 5. Mast cell stabilizers 6. LABA
62
Quick-releif medications: Rescuse
1. SABA Albuterol / Levalbuterol